About us
Renovaro Biosciences, Inc. is a biotechnology company committed to developing advanced allogenic cell and gene therapies to promote stronger immune system responses potentially for long-term or life-long cancer remission in some of the deadliest cancers, and potentially to treat or cure serious infectious diseases such as HIV and Hepatitis B virus (HBV) infection. F
- Website
-
www.renovarobio.com
External link for Renovaro Biosciences Inc.
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Los Angeles, California
- Type
- Public Company
Locations
-
Primary
2080 Century Park E
Los Angeles, California 90067, US
Employees at Renovaro Biosciences Inc.
-
Francois Binette
Managing Director and President
-
Simon Tarsh
Board Member, Audit Committee Chair, Interim CFO. Strategic Advisor - Operating Models, Shared Services and BPO, Retired Deloitte Consulting Partner
-
Argisht Karapetyan, CPA
Vice President of Finance & Corporate Controller
-
Sheila Ahmadi
Program & Project Management | Development Operations I Biotech & Biosiences